NIH-funded research R21 grant

Understanding how bacteria communicate and affect the immune system

Official title: Nucleic Acids and Pneumococcal Extracellular Vesicles: the Who, How and Why?

Funded at Carnegie-Mellon University · NIH-11110461 · Data updated 2026-11-12

This study is looking at how a harmful germ called Streptococcus pneumoniae talks to other bacteria and our cells using tiny bubbles, which could help us understand how it causes infections and how we might treat them better.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionCarnegie-Mellon University
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startJune 7, 2024
Project endApril 30, 2026
Funding year2025
Award (this year)$227,833
NIH project number5R21AI182784-02
Project IDNIH-11110461 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from infections caused by Streptococcus pneumoniae or those at high risk for such infections.

Less likely to help

Patients with infections caused by other types of bacteria unrelated to Streptococcus pneumoniae may not benefit from this research.

What this research studies

This research investigates how Streptococcus pneumoniae, a harmful bacterium, uses tiny vesicles to communicate with other bacteria and human cells. By studying these vesicles, the research aims to uncover how they carry genetic material that can influence bacterial behavior and contribute to disease. The project will explore the mechanisms behind this communication and how it affects the immune response, potentially leading to new therapeutic strategies. Patients may benefit from insights gained about bacterial infections and their treatment.

Why it matters

Potential benefit: If successful, this research could lead to new therapies targeting bacterial communication, improving treatment options for infections caused by Streptococcus pneumoniae.

How similar studies have gone: Other research has shown promise in targeting bacterial communication pathways, suggesting that this approach could yield significant insights and advancements.

Where this research is happening

  • Carnegie-Mellon University
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Hiller, Natalia Luisa — Carnegie-Mellon University
  • Study coordinator: Hiller, Natalia Luisa

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.